Sacituzumab Govitecan and Q901 in Advanced TNBC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sacituzumab Govitecan and Q901 in Advanced TNBC	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Not yet recruiting	Phase 2	2026-08-26		NCT07788222

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Yonsei University	213

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials